EDVA Earnings Endovia Health Sciences, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Quarterly results
EPS
Reported EPS history
1–14 of 14
| Q1 2026 | 2026-03-31 | -0.47 | 2026-05-20 | 10-Q |
| FY 2025 | 2025-12-31 | -11.97 | 2026-04-15 | 10-K |
| Q1 2026 | 2025-03-31 | -1.97 | 2026-05-20 | 10-Q |
| FY 2025 | 2024-12-31 | -17.68 | 2026-04-15 | 10-K |
| Q3 2023 | 2023-09-30 | -0.36 | 2023-11-14 | 10-Q |
| Q2 2023 | 2023-06-30 | -0.22 | 2023-08-14 | 10-Q |
| Q3 2023 | 2022-09-30 | -0.46 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.32 | 2023-08-14 | 10-Q |
| Q1 2022 | 2022-03-31 | -0.16 | 2022-05-16 | 10-Q |
| FY 2021 | 2021-12-31 | -1.02 | 2022-03-31 | 10-K |
| Q1 2022 | 2021-03-31 | -0.19 | 2022-05-16 | 10-Q |
| FY 2021 | 2020-12-31 | -1.06 | 2022-03-31 | 10-K |
| FY 2019 | 2019-12-31 | -0.04 | 2020-03-27 | 10-K |
| FY 2019 | 2018-12-31 | 0.01 | 2020-03-27 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.